Advisory and research firm, Everest Group, in its report, IT Outsourcing in Life Sciences Industry Service Provider Landscape with PEAK Matrix Assessment and Profile Compendium 2013, has recognized HCL Technologies as a “Leader” and “Star Performer category in life sciences IT outsourcing. HCL was recognized for its continual growth on a large scale, and for its significant investment in life science proprietary solutions.
R. Srikrishna, President Infrastructure Services and Life Sciences & Healthcare, HCL, said, Everest recognition is a great acknowledgement of HCL’s strong momentum and success in its life sciences business, resulting from our strong focus on solution development and significant pharma deal wins in the application, infrastructure and ERP space globally. During the last financial year, HCL’s healthcare and life sciences posted incremental revenue of 45.2%, which is way ahead when compared to the other leading operating players for the same time period.
The Life Sciences industry is keenly adopting next-generation IT with an eye on enabling strategic initiatives. HCL’s investments in its services portfolio and domain solutions have created success in large, multi-year IT service contracts for life sciences customers. HCL not only continued to maintain its position as a Leader on the PEAK Matrix but also enhanced its capabilities and achieved above average growth to be a Star Performer, said Jimit Arora, Vice- President, Everest Group.
This report by Everest Group assessed 14 ITO service providers in the life sciences vertical with a focus on large, annuity-based and multi-year application outsourcing relationships.
Keep reading
Related stories

Networking
RUCKUS Networks deepens commitment to India through local manufacturing
24 September 2026

Networking
NordVPN Uncovers Android Banking Trojan Impersonating More Than 65 Brands
21 August 2026

Networking
TP-Link Unveils Tapo H110 Smart IR & IoT Hub in India
19 August 2026

Networking
Nelco Collaborates with Elveo to Offer D2D and IoT Connectivity to South Asian Markets
18 August 2026
